Is pregnancy-associated plasma protein A (PAPP-A) an immunomodulator during human pregnancy?
D000276:Adjuvants, Immunologic; D001665:Binding Sites; D003169:Complement Inactivator Proteins; D003656:Decidua / Q000166:cytology / Q000276:immunology; D004717:Endometrium / Q000166:cytology / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006651:Histocytochemistry; D006801:Humans; D007124:Immunoenzyme Techniques; D008213:Lymphocyte Activation / Q000187:drug effects; D008871:Microvilli / Q000276:immunology; D010920:Placenta / Q000166:cytology / Q000276:immunology / Q000648:ultrastructure; D010928:Placental Lactogen / Q000096:biosynthesis; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000494:pharmacology*; D011266:Pregnancy-Associated Plasma Protein-A / Q000096:biosynthesis / Q000276:immunology / Q000494:pharmacology* / Q000502:physiology; D011863:Radioimmunoassay; D013997:Time Factors; D014327:Trophoblasts / Q000378:metabolism
D000276:Adjuvants, Immunologic; D003169:Complement Inactivator Proteins; D011257:Pregnancy Proteins; D010928:Placental Lactogen; D011266:Pregnancy-Associated Plasma Protein-A